Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease
- PMID: 16397425
- DOI: 10.1097/01.inf.0000197563.03895.91
Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease
Abstract
The data currently available on the epidemiology, severity and economic burden of nosocomial rotavirus (RV) infections in children younger than 5 years of age in the major European countries are reviewed. In most studies, RV was found to be the major etiologic agent of pediatric nosocomial diarrhea (31-87%), although the number of diarrhea cases associated with other virus infections (eg, noroviruses, astroviruses, adenoviruses) is increasing quickly and almost equals that caused by RVs. Nosocomial RV (NRV) infections are mainly associated with infants 0-5 months of age, whereas community-acquired RV disease is more prevalent in children 6-23 months of age. NRV infections are seasonal in most countries, occurring in winter; this coincides with the winter seasonal peak of other childhood virus infections (eg, respiratory syncytial virus and influenza viruses), thus placing a heavy burden on health infrastructures. A significant proportion (20-40%) of infections are asymptomatic, which contributes to the spread of the virus and might reduce the efficiency of prevention measures given as they are implemented too late. The absence of effective surveillance and of reporting of NRV infections in any of the 6 countries studied (France, Germany, Italy, Poland, Spain and the United Kingdom) results in severe underreporting of NRV cases in hospital databases and therefore in limited awareness of the importance of NRV disease at country level. The burden reported in the medical literature is potentially significant and includes temporary reduction in the quality of children's lives, increased costs associated with the additional consumption of medical resources (increased length of hospital stay) and constraints on parents'/hospital staff's professional lives. The limited robustness and comparability of studies, together with an evolving baseline caused by national changes in health care systems, do not presently allow a complete and accurate overview of NRV disease at country level to be obtained. RV is highly contagious, and the efficiency of existing prevention measures (such as handwashing, isolation and cohorting) is variable, but low at the global level because of the existence of numerous barriers to implementation (eg, lack of staff, high staff turnover, inadequate hospital infrastructure). Prevention of RV infection by mass vaccination could have a positive impact on the incidence of NRV by reducing the number of children hospitalized for gastroenteritis, therefore reducing the number of hospital cross-infections and associated costs.
Similar articles
-
Nosocomial rotavirus infection: An up to date evaluation of European studies.Hum Vaccin Immunother. 2016 Sep;12(9):2413-8. doi: 10.1080/21645515.2016.1183858. Epub 2016 May 16. Hum Vaccin Immunother. 2016. PMID: 27185183 Free PMC article. Review.
-
Rotavirus, respiratory syncytial virus and non-rotaviral gastroenteritis analysis of hospital readmissions in England and Wales.Acta Paediatr. 2013 Apr;102(4):e158-63. doi: 10.1111/apa.12124. Epub 2013 Jan 9. Acta Paediatr. 2013. PMID: 23289533
-
The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections.BMC Infect Dis. 2013 Mar 1;13:112. doi: 10.1186/1471-2334-13-112. BMC Infect Dis. 2013. PMID: 23452879 Free PMC article.
-
Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review.BMC Infect Dis. 2012 Mar 19;12:62. doi: 10.1186/1471-2334-12-62. BMC Infect Dis. 2012. PMID: 22429601 Free PMC article.
-
International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection.Pediatr Infect Dis J. 2001 Aug;20(8):784-91. doi: 10.1097/00006454-200108000-00013. Pediatr Infect Dis J. 2001. PMID: 11734742
Cited by
-
Nosocomial rotavirus gastroenterocolitis in a large tertiary paediatric hospital in Warsaw, 2006-2010.Arch Med Sci. 2013 Jun 20;9(3):493-8. doi: 10.5114/aoms.2013.33177. Epub 2013 Feb 10. Arch Med Sci. 2013. PMID: 23847672 Free PMC article.
-
Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?Health Econ Rev. 2013 Nov 18;3(1):27. doi: 10.1186/2191-1991-3-27. Health Econ Rev. 2013. PMID: 24246029 Free PMC article.
-
Do current cost-effectiveness analyses reflect the full value of childhood vaccination in Europe? A rotavirus case study.Hum Vaccin Immunother. 2014;10(8):2290-4. doi: 10.4161/hv.29090. Hum Vaccin Immunother. 2014. PMID: 25424934 Free PMC article. Review.
-
Role of vaccination in the sustainability of healthcare systems.J Mark Access Health Policy. 2015 Aug 12;3. doi: 10.3402/jmahp.v3.27043. eCollection 2015. J Mark Access Health Policy. 2015. PMID: 27123188 Free PMC article.
-
Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013-2018.BMC Infect Dis. 2021 Nov 6;21(1):1138. doi: 10.1186/s12879-021-06841-x. BMC Infect Dis. 2021. PMID: 34742235 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical